Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David T. Howton currently holds 97,859 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David T. Howton has been a net seller of SRPT stock. They have purchased $0 and sold $43.5M worth of shares.
David T. Howton's most recent insider trade was on Feb 4, 2026, when they sold 18,894 shares at $6.44 per share.
David T. Howton serves as Executive at Sarepta Therapeutics, Inc. (SRPT). They have executed 74 insider transactions totaling $43.5M over their tenure at the company.
David T. Howton holds the position of Executive at Sarepta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
David T. Howton has shown a selling trading pattern, with $0 in total purchases and $43.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David T. Howton was on Dec 13, 2019, when they sold $9.8M worth of SRPT shares. This transaction involved 78,000 shares at $125.50 per share.
David T. Howton currently owns 97,859 shares of Sarepta Therapeutics, Inc. (SRPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David T. Howton's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David T. Howton has 74 Form 4 filings on record as an insider at Sarepta Therapeutics, Inc..
Set alerts for David T. Howton and 40,000+ other insiders.